Press Release Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference Aug 24
Press Release Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates Aug 13
Press Release Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma Aug 10